Management of Hepatic Lymph Nodes during Liver Resection for Colorectal Cancer
Author Information
Author(s): Gurusamy Kurinchi S., Imber Charles, Davidson Brian R.
Primary Institution: University Department of Surgery, UCL and Royal Free Hospital NHS Trust
Hypothesis
What is the role of lymphadenectomy in the resection of liver metastases from colorectal cancer?
Conclusion
There is currently no evidence of survival benefit for routine or selective lymphadenectomy in patients with colorectal liver metastases.
Supporting Evidence
- The overall prevalence of positive lymph nodes was 16.0%.
- 3-year survival rates were 11.3% for node-positive patients compared to 53.9% for node-negative patients.
- 5-year survival rates were 1.5% for node-positive patients compared to 32.1% for node-negative patients.
- Routine lymphadenectomy did not show a survival benefit in the studies reviewed.
- Patients with positive lymph nodes had significantly lower odds of survival.
Takeaway
This study looked at whether removing lymph nodes during liver surgery for cancer helps patients live longer, and it found that it doesn't seem to make a difference.
Methodology
A systematic review and meta-analysis of studies on hepatic lymph node involvement in colorectal liver metastases.
Potential Biases
Potential bias due to the lack of randomized controlled trials and varying surgical techniques.
Limitations
No randomized controlled trials were found comparing liver resection with or without lymphadenectomy.
Participant Demographics
The studies included a total of 926 patients with colorectal liver metastases.
Statistical Information
P-Value
0.12 for 3-year survival, 0.08 for 5-year survival
Confidence Interval
95% CI 0.06 to 0.24 for 3-year survival, 95% CI 0.03 to 0.22 for 5-year survival
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website